Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Trisenox

(TRY-seh-nox)
A drug used to treat acute promyelocytic leukemia that has a certain chromosome abnormality or a fusion gene called PML::RARA. It is used with tretinoin in some newly diagnosed adults. It is also used alone in patients whose cancer has not gotten better or has come back after treatment with other anticancer drugs. Trisenox is also being studied in the treatment of other types of cancer. Trisenox damages a fusion protein made by the PML::RARA fusion gene. This may help keep cancer cells from growing and may kill them. Also called arsenic trioxide.
Search NCI's Dictionary of Cancer Terms